21st Annual Peptide Therapeutics Symposium
October 20 – 21, 2026
Scripps Seaside Forum,
8610 Kennel Way, La Jolla, CA 92037 |
| Tuesday, October 20, 2026 |
| 8:00 am - 4:00 pm | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00 am - 8:30 am | Breakfast & Poster Viewing
The Scripps Seaside Forum Lobby |
| 8:30 am - 5:00 pm | 21st Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30 am - 8:35 am | "Opening Remarks"
|
| 8:35 am - 10:05 am | Plenary Lectures
|
| 8:35 am - 9:20 am | Jonathan Campbell, Ph.D.,
Associate Professor of Medicine, Duke University
Mechanisms and Physiology of GIP |
| 9:20 am - 10:05 am | Robert P. Doyle Ph.D.,
Jack and Laura H. Milton '51 Chair in Chemistry, Syracuse University
From Stress Cytokine to Drug Target: Developing Peptide Antagonists of the GDF15-GFRAL-RET Axis
|
| 10:05 am - 10:35 am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:35 am - 12:05 pm | Session I
|
| 10:35 am - 11:05 am | L-C Campeau, Ph.D.,
Associate Vice President, Head of Small Molecule Process R&D, Merck & Co., Inc.
The Evolution Peptide Manufacturing: The Story of the Enlicitide Synthesis and Beyond
|
| 11:05 am - 11:35 am | Andrew DeMaria, Ph.D.
Senior Scientist, Johnson & Johnson Innovative Medicine
Breaking Barriers – Redefining Oral Peptide Drug Delivery through Molecular and Formulation Design |
| 11:35 am - 12:05 pm | Mike Hackett, Ph.D., DABT
Senior Director of Pharmacology and Toxicology, MBX Biosciences
The Precision Endocrine Peptide (PEP) Platform: Optimized Pharmacokinetics to Reduce Dosing Frequency and Improve Tolerability in Endocrine and Metabolic Diseases
|
| 12:05 pm - 1:30 pm | Lunch & Poster Viewing
The Scripps Seaside Forum Lawn |
| 1:30 pm - 3:00 pm | Session II
|
| 1:30 pm - 2:00 pm | David Van Valen, MD, Ph.D.
California Institute of Technology |
| 2:00 pm - 2:30 pm | Gaurav Bhardwaj, Ph.D.,
Associate Professor of Medicinal Chemistry, University of Washington
Generative Peptide Design for Diverse Structures and Functions |
| 2:30 pm - 3:00 pm | Ivan Anishchenko, Ph.D.
Senior Director of Deep Learning, Vilya Therapeutics
Predicting How Chemically Complex Peptides Bind Their Targets |
| 3:00 pm– 3:30 pm | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 3:30 pm - 5:00 pm | Session III
|
| 3:30 pm - 4:00 pm | Ahmed H. Badran, Ph.D.,
Associate Professor, Department of Chemistry, The Scripps Research Institute
Programmable Biosynthesis of New-to-Nature Molecules |
| 4:00 pm - 4:30 pm | Guy Salama, Ph.D.,
Univerity of Pittsburgh, School of Medicine
Mechanisms of Cardioprotection by Relaxin-2 in a Rat model of Heart Failure with Preserved Ejection Fraction. Role of Glucocorticoid receptors (GR) Activation |
| 4:30 pm - 5:00 pm | Daniele Catalucci, Ph.D.,
Co-Founder and Cardiovascular Science Advisor, NanoPhoria
From Lung to Heart: Inhalable Nano-in-Micro Delivery of a First-in Class Peptide Drives Cardiac Recovery in HFrEF |
| 5:00 pm - 6:30 pm | Opening Reception
The Scripps Seaside Forum Lawn |
| Wednesday, October 22, 2026 |
| 8:00 am - 10:00 am | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00 am - 8:30 am | Breakfast & Poster Viewing
The Scripps Seaside Forum Lobby |
| 8:30 am - 1:00 pm | 21st Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30 am - 8:35 am | "Welcoming Remarks"
|
| 8:35 am - 10:05 am | Plenary Lectures
|
| 8:35 am - 9:20 am | Tamer Coskun, MD, Ph.D.,
Eli Lilly & Company |
| 9:20 am - 10:05 am | Debbie Hay, Ph.D.,
Professor, School of Pharmacy and Pharmacology, University of Otago
Amylin Receptor Biology |
| 10:05 am - 10:35 am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:35 am - 12:05 pm | Session IV |
| 10:35 am - 11:05 am | Jonathan Roth, Ph.D.
Biotech Consulting, Metabolic Diseases
It Still Takes Two to Tango: Amylin-Based Synergies in the Incretin Era |
| 11:05 am - 11:35 am | Denis Roy, Ph.D.,
Vice President, Nonclinical Safety & Development, SciLucent
Bridging Discovery to IND — Navigating the Transition from Peptide Lead Optimization to Nonclinical Toxicology Development |
| 11:35 am - 12:05 pm | Neil Butt, Ph.D.,
Orbit Discovery |
| 12:05 pm - 12:55 pm | Amylin Panel
Moderator: David Parkes, Ph.D., President, DGP Scientific Inc.,
Debbie Hay, Ph.D., Professor,School of Pharmacy and Pharmacology, University of Otago"
Tamer Coskun, MD, Ph.D., Eli Lilly & Company
Jonathon Roth Ph.D., Biotech Consulting, Metabolic Diseases
|
| 12:55 pm - 1:00 pm | "Closing Remarks"
|
| 1:00 pm - 2:00 pm | Networking Lunch
The Scripps Seaside Forum Lawn |
